|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
|
EP2187900B1
(en)
*
|
2007-08-16 |
2016-11-09 |
The Schepens Eye Research Institute, Inc. |
Therapeutic compositions for treatment of inflammation of ocular and adnexal tissues
|
|
CA2711696C
(en)
*
|
2008-01-09 |
2021-10-26 |
Reza Dana |
Therapeutic compositions for treatment of ocular inflammatory disorders
|
|
US20110223169A1
(en)
*
|
2008-11-26 |
2011-09-15 |
Stern Michael E |
Il-17 antibody inhibitor for treating dry eye
|
|
EP2385839B1
(en)
|
2009-01-09 |
2014-11-26 |
The Schepens Eye Research Institute, Inc. |
Therapeutic compositions for treatment of corneal disorders
|
|
US20120014970A1
(en)
*
|
2009-01-09 |
2012-01-19 |
Reza Dana |
Therapeutic Compositions for Treatment of Corneal Disorders
|
|
US20110038871A1
(en)
*
|
2009-08-11 |
2011-02-17 |
Veena Viswanth |
Ccr2 inhibitors for treating conditions of the eye
|
|
EP2473523A2
(en)
*
|
2009-08-31 |
2012-07-11 |
Amplimmune, Inc. |
Methods and compositions for the inhibition of transplant rejection
|
|
US9011861B2
(en)
|
2010-02-25 |
2015-04-21 |
Schepens Eye Research Institute |
Therapeutic compositions for the treatment of dry eye disease
|
|
RU2585491C2
(ru)
|
2010-06-04 |
2016-05-27 |
Борд Оф Риджентс, Зе Юниверсити Оф Техас Систем |
Регуляция метаболизма с помощью mir-378
|
|
US20120004298A1
(en)
*
|
2010-06-30 |
2012-01-05 |
Hassan Chaouk |
Ophthalmic devices containing chemokine antagonists
|
|
HRP20230776T1
(hr)
|
2010-07-29 |
2023-10-27 |
Buzzard Pharmaceuticals AB |
Himerni antagonisti receptora il-1 tipa i
|
|
WO2012148547A1
(en)
*
|
2011-02-24 |
2012-11-01 |
The Schepens Eye Research Institute, Inc. |
Compositions and methods for treating inflammatory conditions of the ocular surface
|
|
US10451897B2
(en)
|
2011-03-18 |
2019-10-22 |
Johnson & Johnson Vision Care, Inc. |
Components with multiple energization elements for biomedical devices
|
|
US9812730B2
(en)
|
2011-08-02 |
2017-11-07 |
Johnson & Johnson Vision Care, Inc. |
Biocompatible wire battery
|
|
US8857983B2
(en)
|
2012-01-26 |
2014-10-14 |
Johnson & Johnson Vision Care, Inc. |
Ophthalmic lens assembly having an integrated antenna structure
|
|
EP2809660B1
(en)
|
2012-02-02 |
2016-01-20 |
Ensemble Therapeutics Corporation |
Macrocyclic compounds for modulating il-17
|
|
MX363182B
(es)
|
2012-09-12 |
2019-03-13 |
Novaliq Gmbh |
Composiciones que comprenden mezclas de alcanos semifluorados.
|
|
WO2014093870A2
(en)
*
|
2012-12-13 |
2014-06-19 |
The Schepens Eye Research Institute, Inc. |
Use of c-c chemokine receptor type 7 (ccr7) inhibitors
|
|
WO2014107737A2
(en)
*
|
2013-01-07 |
2014-07-10 |
Eleven Biotherapeutics, Inc. |
Local delivery of il-17 inhibitors for treating ocular disease
|
|
TWI623313B
(zh)
*
|
2013-03-13 |
2018-05-11 |
Santen Pharmaceutical Co Ltd |
瞼板腺功能障礙之治療劑
|
|
JP6450364B2
(ja)
|
2013-03-13 |
2019-01-09 |
セセン バイオ, インコーポレイテッド |
眼送達のためのキメラサイトカイン製剤
|
|
US9383593B2
(en)
|
2014-08-21 |
2016-07-05 |
Johnson & Johnson Vision Care, Inc. |
Methods to form biocompatible energization elements for biomedical devices comprising laminates and placed separators
|
|
US10361405B2
(en)
|
2014-08-21 |
2019-07-23 |
Johnson & Johnson Vision Care, Inc. |
Biomedical energization elements with polymer electrolytes
|
|
US9793536B2
(en)
|
2014-08-21 |
2017-10-17 |
Johnson & Johnson Vision Care, Inc. |
Pellet form cathode for use in a biocompatible battery
|
|
US10381687B2
(en)
|
2014-08-21 |
2019-08-13 |
Johnson & Johnson Vision Care, Inc. |
Methods of forming biocompatible rechargable energization elements for biomedical devices
|
|
US10361404B2
(en)
|
2014-08-21 |
2019-07-23 |
Johnson & Johnson Vision Care, Inc. |
Anodes for use in biocompatible energization elements
|
|
US9715130B2
(en)
|
2014-08-21 |
2017-07-25 |
Johnson & Johnson Vision Care, Inc. |
Methods and apparatus to form separators for biocompatible energization elements for biomedical devices
|
|
US10627651B2
(en)
|
2014-08-21 |
2020-04-21 |
Johnson & Johnson Vision Care, Inc. |
Methods and apparatus to form biocompatible energization primary elements for biomedical devices with electroless sealing layers
|
|
US9941547B2
(en)
|
2014-08-21 |
2018-04-10 |
Johnson & Johnson Vision Care, Inc. |
Biomedical energization elements with polymer electrolytes and cavity structures
|
|
US9599842B2
(en)
|
2014-08-21 |
2017-03-21 |
Johnson & Johnson Vision Care, Inc. |
Device and methods for sealing and encapsulation for biocompatible energization elements
|
|
AR103173A1
(es)
|
2014-12-22 |
2017-04-19 |
Novarits Ag |
Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17
|
|
KR101812611B1
(ko)
|
2015-04-24 |
2017-12-28 |
포항공과대학교 산학협력단 |
스마트 콘택트 렌즈 및 스마트 안경
|
|
US10816823B2
(en)
*
|
2015-05-04 |
2020-10-27 |
École Polytechnique Fédérale de Lausanne |
Ophthalmic contact lens with compressible affinity matrix
|
|
US20170087100A1
(en)
|
2015-09-30 |
2017-03-30 |
Novaliq Gmbh |
Semifluorinated compounds and their compositions
|
|
WO2017120479A1
(en)
|
2016-01-07 |
2017-07-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutics for ocular immunoinflammatory diseases
|
|
US10345620B2
(en)
|
2016-02-18 |
2019-07-09 |
Johnson & Johnson Vision Care, Inc. |
Methods and apparatus to form biocompatible energization elements incorporating fuel cells for biomedical devices
|
|
EP3490542A4
(en)
*
|
2016-07-26 |
2020-07-08 |
Flagship Pioneering Innovations V, Inc. |
NEUROMODULATION COMPOSITIONS AND RELATED THERAPEUTIC METHODS FOR THE TREATMENT OF CANCER BY MODULATION OF AN ANTI-CANCER RESPONSE
|
|
MX381639B
(es)
|
2016-12-23 |
2025-03-13 |
Novaliq Gmbh |
Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
|
|
CA3088957A1
(en)
*
|
2017-01-17 |
2018-07-26 |
Tufts Medical Center, Inc. |
Adoptive transfer of plasmacytoid dendritic cells to prevent or treat ocular diseases and conditions
|
|
GB201709456D0
(en)
|
2017-06-14 |
2017-07-26 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
CN111182893A
(zh)
|
2017-10-04 |
2020-05-19 |
诺瓦利克有限责任公司 |
包含f6h8的眼用组合物
|
|
CN111601799B
(zh)
|
2018-01-15 |
2023-06-09 |
Ucb生物制药有限责任公司 |
作为Il-17调节剂的稠合咪唑衍生物
|
|
US11619832B2
(en)
*
|
2018-03-08 |
2023-04-04 |
Coopervision International Limited |
Identification of contact lens wearers predisposed to contact lens discomfort
|
|
JP2021516966A
(ja)
*
|
2018-03-09 |
2021-07-15 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
組織への生物学的薬物の送達
|
|
JP7855312B2
(ja)
|
2018-04-27 |
2026-05-08 |
ノバリック ゲーエムベーハー |
緑内障の治療のためのタフルプロストを含む眼科用組成物
|
|
WO2020011731A1
(en)
|
2018-07-12 |
2020-01-16 |
UCB Biopharma SRL |
Spirocyclic indane analogues as il-17 modulators
|
|
CA3112031A1
(en)
|
2018-10-12 |
2020-04-16 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
GB201820165D0
(en)
|
2018-12-11 |
2019-01-23 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
GB201820166D0
(en)
|
2018-12-11 |
2019-01-23 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
JP7137696B2
(ja)
|
2019-05-14 |
2022-09-14 |
プロヴェンション・バイオ・インコーポレイテッド |
1型糖尿病を予防するための方法および組成物
|
|
GB201909191D0
(en)
|
2019-06-26 |
2019-08-07 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
GB201909194D0
(en)
|
2019-06-26 |
2019-08-07 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
GB201909190D0
(en)
|
2019-06-26 |
2019-08-07 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
CN114449999A
(zh)
|
2019-09-06 |
2022-05-06 |
诺瓦利克有限责任公司 |
用于治疗葡萄膜炎的眼用组合物
|
|
JP7667142B2
(ja)
*
|
2019-09-30 |
2025-04-22 |
ヤンセン ファーマシューティカ エヌ.ベー. |
大分子モジュレータを用いたil-17標的結合アッセイのための組成物及び方法
|
|
WO2021170627A1
(en)
|
2020-02-25 |
2021-09-02 |
UCB Biopharma SRL |
Difluorocyclohexyl derivatives as il-17 modulators
|
|
WO2021170631A1
(en)
|
2020-02-25 |
2021-09-02 |
UCB Biopharma SRL |
Difluorocyclohexyl derivatives as il-17 modulators
|
|
WO2021191689A2
(en)
*
|
2020-03-05 |
2021-09-30 |
Yuyu Pharma, Inc. |
Treatment of inflammatory diseases with peptides and pharmaceutical compositions
|
|
CN115702024A
(zh)
|
2020-04-07 |
2023-02-14 |
Ucb生物制药有限责任公司 |
用作il-17调节剂的二氟环己基衍生物
|
|
WO2021204800A1
(en)
|
2020-04-07 |
2021-10-14 |
UCB Biopharma SRL |
Difluorocyclohexyl derivatives as il-17 modulators
|
|
MX2022014925A
(es)
|
2020-05-27 |
2023-01-04 |
Sanofi Sa |
Moduladores de il-17a.
|
|
EP4157828A1
(en)
|
2020-05-27 |
2023-04-05 |
Sanofi |
Il-17a modulators
|
|
KR20230092863A
(ko)
|
2020-06-11 |
2023-06-26 |
프로벤션 바이오, 인코포레이티드 |
제1형 당뇨병을 예방하기 위한 방법 및 조성물
|
|
WO2022006076A1
(en)
*
|
2020-07-01 |
2022-01-06 |
The Johns Hopkins University |
Ocular treatment compositions and methods
|
|
WO2022061132A1
(en)
*
|
2020-09-17 |
2022-03-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Ophthalmic devices for the treatment or amelioration of dry eye disease, and related methods of use
|
|
WO2022096412A1
(en)
|
2020-11-09 |
2022-05-12 |
UCB Biopharma SRL |
Dicyclopropylmethyl derivatives as il-17 modulators
|
|
WO2022096411A1
(en)
|
2020-11-09 |
2022-05-12 |
UCB Biopharma SRL |
Dicyclopropylmethyl derivatives as il-17 modulators
|
|
US20240140951A1
(en)
|
2020-12-14 |
2024-05-02 |
UCB Biopharma SRL |
Imidazopyridazine derivatives as il-17 modulators
|
|
MX2023013851A
(es)
|
2021-05-24 |
2023-12-08 |
Provention Bio Inc |
Metodos para el tratamiento de diabetes tipo 1.
|
|
AR126255A1
(es)
|
2021-07-01 |
2023-10-04 |
UCB Biopharma SRL |
Derivados de imidazotriazina como moduladores de il-17
|
|
WO2023215269A1
(en)
*
|
2022-05-06 |
2023-11-09 |
The Regents Of The University Of California |
Lacripep promotes neuroregeneration and maintains epithelial progenitor cell identity
|
|
EP4536189A4
(en)
*
|
2022-06-08 |
2026-07-29 |
The Schepens Eye Research Inst Inc |
METHODS OF TREATING DRY EYE DISEASE
|
|
GB202210731D0
(en)
|
2022-07-22 |
2022-09-07 |
UCB Biopharma SRL |
Therapeutic agents
|
|
WO2024102746A1
(en)
*
|
2022-11-08 |
2024-05-16 |
Microcures, Inc. |
Methods and agents for treating neurotrophic keratitis
|
|
TW202430165A
(zh)
|
2022-12-02 |
2024-08-01 |
丹麥商理奧藥品公司 |
Il-17之小分子調節劑
|
|
JP2026500183A
(ja)
|
2022-12-09 |
2026-01-06 |
サノフイ |
治療用化合物
|
|
WO2024126249A1
(en)
|
2022-12-14 |
2024-06-20 |
UCB Biopharma SRL |
Imidazotriazine derivatives as il-17 modulators
|
|
GB202218860D0
(en)
|
2022-12-14 |
2023-01-25 |
Ucb Biopharma Sprl |
Therapeutic agents
|
|
GB202218846D0
(en)
|
2022-12-14 |
2023-01-25 |
UCB Biopharma SRL |
Therapeutic agents
|
|
GB202305587D0
(en)
|
2023-04-17 |
2023-05-31 |
UCB Biopharma SRL |
Therapeutic agents
|
|
GB202305585D0
(en)
|
2023-04-17 |
2023-05-31 |
UCB Biopharma SRL |
Therapeutic agents
|
|
WO2025104230A1
(en)
|
2023-11-17 |
2025-05-22 |
Sanofi |
Benzoxazoles as modulators of il-17a
|
|
WO2025248073A1
(en)
|
2024-05-30 |
2025-12-04 |
Sanofi |
Therapeutic compounds
|
|
WO2026073936A1
(en)
|
2024-10-02 |
2026-04-09 |
UCB Biopharma SRL |
Imidazotriazine derivatives as il-17 modulators
|
|
WO2026073929A1
(en)
|
2024-10-02 |
2026-04-09 |
UCB Biopharma SRL |
Imidazotriazine derivatives as il-17 modulators
|
|
WO2026073937A1
(en)
|
2024-10-02 |
2026-04-09 |
UCB Biopharma SRL |
Imidazotriazine derivatives as il-17 modulators
|